IndraLab

Statements

USP13 inhibits MAPK. 3 / 3
| 3
reach
"As expected, USP13 inhibited inflammatory pathways, including MAPK and NF-κB signaling pathways, in the livers of NAFLD mice."
39033101
reach
"In light of the above findings that USP13 inhibits the MAPK and NF-κB signaling pathways, we considered TAK1, a known upstream kinase of these pathways, as a potential downstream target of USP13."
39033101
reach
"For instance, in non-small-cell lung cancer (NSCLC), downregulation of USP13 inhibits MAPK/AKT signaling (Han et al., 2016)."
35445009